News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
710,425 Results
Type
Article (45390)
Company Profile (713)
Press Release (664306)
Multimedia
Podcasts (122)
Webinars (23)
Section
Business (201217)
Career Advice (2264)
Deals (36608)
Drug Delivery (148)
Drug Development (81735)
Employer Resources (168)
FDA (16203)
Job Trends (15170)
News (341847)
Policy (30052)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (2135)
Academic (1)
Accelerated approval (46)
Adcomms (27)
Allergies (168)
Alliances (48494)
ALS (210)
Alzheimer's disease (1760)
Antibody-drug conjugate (ADC) (467)
Approvals (16551)
Artificial intelligence (649)
Autoimmune disease (276)
Automation (50)
Bankruptcy (383)
Best Places to Work (11280)
BIOSECURE Act (23)
Biosimilars (222)
Biotechnology (441)
Bladder cancer (185)
Brain cancer (72)
Breast cancer (711)
Cancer (5771)
Cardiovascular disease (467)
Career advice (1906)
Career pathing (45)
CAR-T (340)
CDC (27)
Celiac Disease (1)
Cell therapy (941)
Cervical cancer (43)
Clinical research (70618)
Collaboration (2112)
Company closure (6)
Compensation (1360)
Complete response letters (96)
COVID-19 (2577)
CRISPR (112)
C-suite (1119)
Cystic fibrosis (157)
Data (7535)
Decentralized trials (3)
Denatured (18)
Depression (169)
Dermatology (68)
Diabetes (557)
Diagnostics (6990)
Digital health (53)
Diversity (8)
Diversity, equity & inclusion (39)
Drug discovery (320)
Drug pricing (211)
Drug shortages (30)
Duchenne muscular dystrophy (276)
Earnings (88257)
Editorial (67)
Employer branding (24)
Employer resources (149)
Events (119345)
Executive appointments (1106)
FDA (19811)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (13)
Frontotemporal dementia (33)
Funding (1706)
Gene editing (244)
Generative AI (61)
Gene therapy (754)
GLP-1 (1094)
Government (3538)
Grass and pollen (8)
Guidances (395)
Healthcare (17202)
HIV (79)
Huntington's disease (57)
IgA nephropathy (94)
Immunology and inflammation (312)
Immuno-oncology (96)
Indications (172)
Infectious disease (2912)
Inflammatory bowel disease (216)
Inflation Reduction Act (13)
Influenza (134)
Intellectual property (285)
Interviews (449)
IPO (17427)
IRA (52)
Job creations (4253)
Job search strategy (1557)
JPM (66)
Kidney cancer (20)
Labor market (93)
Layoffs (644)
Leadership (42)
Legal (7370)
Liver cancer (104)
Longevity (28)
Lung cancer (786)
Lymphoma (424)
Machine learning (58)
Management (60)
Manufacturing (1039)
MASH (189)
Medical device (14223)
Medtech (14314)
Mergers & acquisitions (20389)
Metabolic disorders (1483)
mRNA (217)
Multiple sclerosis (183)
NASH (20)
Neurodegenerative disease (420)
Neuropsychiatric disorders (115)
Neuroscience (3277)
Neurotech (1)
NextGen: Class of 2026 (6328)
Non-profit (3088)
Now hiring (76)
Obesity (705)
Opinion (331)
Ovarian cancer (204)
Pain (243)
Pancreatic cancer (293)
Parkinson's disease (362)
Partnered (34)
Patents (591)
Patient recruitment (654)
Peanut (63)
People (60075)
Pharmaceutical (128)
Pharmacy benefit managers (31)
Phase 1 (22315)
Phase 2 (31383)
Phase 3 (23292)
Pipeline (7847)
Policy (305)
Postmarket research (2103)
Preclinical (9535)
Press Release (69)
Prostate cancer (285)
Psychedelics (60)
Radiopharmaceuticals (341)
Rare diseases (1096)
Real estate (5950)
Recruiting (72)
Regulatory (24344)
Reports (45)
Research institute (2118)
Resumes & cover letters (348)
Rett syndrome (37)
RNA editing (22)
RSV (88)
Schizophrenia (181)
Series A (302)
Series B (219)
Service/supplier (26)
Sickle cell disease (119)
Special edition (29)
Spinal muscular atrophy (171)
Sponsored (43)
Startups (3977)
State (2)
Stomach cancer (20)
Supply chain (127)
Tariffs (100)
The Weekly (102)
Vaccines (1061)
Venture capital (110)
Weight loss (471)
Women's health (108)
Worklife (23)
Date
Today (186)
Last 7 days (728)
Last 30 days (2857)
Last 365 days (31390)
2026 (10428)
2025 (31202)
2024 (36475)
2023 (41101)
2022 (51630)
2021 (55235)
2020 (52434)
2019 (44187)
2018 (33618)
2017 (33524)
2016 (32116)
2015 (37702)
2014 (30398)
2013 (25666)
2012 (27122)
2011 (27231)
2010 (24752)
Location
Africa (747)
Alabama (98)
Alaska (7)
Arizona (273)
Arkansas (14)
Asia (43604)
Australia (7206)
California (12956)
Canada (3664)
China (1369)
Colorado (544)
Connecticut (560)
Delaware (394)
Europe (96155)
Florida (1876)
Georgia (401)
Hawaii (4)
Idaho (61)
Illinois (949)
India (95)
Indiana (607)
Iowa (25)
Japan (518)
Kansas (132)
Kentucky (51)
Louisiana (35)
Maine (83)
Maryland (1425)
Massachusetts (9475)
Michigan (365)
Minnesota (714)
Mississippi (5)
Missouri (151)
Montana (35)
Nebraska (26)
Nevada (139)
New Hampshire (87)
New Jersey (3485)
New Mexico (31)
New York (3381)
North Carolina (1741)
North Dakota (9)
Northern California (6431)
Ohio (373)
Oklahoma (21)
Oregon (50)
Pennsylvania (2559)
Puerto Rico (29)
Rhode Island (52)
South America (1153)
South Carolina (84)
South Dakota (1)
Southern California (5027)
Tennessee (181)
Texas (2060)
United States (45733)
Utah (377)
Vermont (1)
Virginia (312)
Washington D.C. (77)
Washington State (1061)
West Virginia (4)
Wisconsin (133)
Wyoming (2)
710,425 Results for "cell culture company c3".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Gene Therapy Cell Culture Media Market to Reach USD 600.11 Billion by 2035
April 23, 2026
·
1 min read
Press Releases
BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform
March 31, 2026
·
1 min read
Sponsored
Powering the Next Wave of Cell Therapy: From iPSC-Derived Cells to In Vivo Reprogramming
As cell therapy advances toward clinical reality, iPSC-derived cellular products, in vivo reprogramming strategies, and manufacturing-ready reagent platforms are reshaping regenerative medicine and oncology. Recombinant antibodies and drug targets, e.g. endotoxin-free proteins, transmembrane proteins, and site-specifically labeled biomolecules are emerging as indispensable enablers of reproducibility, mechanistic insight, and clinical-scale success.
March 23, 2026
·
4 min read
Layoffs
50 employees impacted as Astellas closes Universal Cells’ Seattle office
By closing the Universal Cells Seattle location, Astellas is reportedly consolidating cell therapy, gene therapy and oncology research at its South San Francisco, California, and Westborough, Massachusetts, sites.
April 14, 2026
·
2 min read
·
Angela Gabriel
Parkinson’s disease
Oryon Splashes Onto Parkinson’s Scene With $42M for Cell Therapy
Oryon Cell Therapies’ lead cell therapy is an autologous treatment designed to replace dopaminergic neurons in patients with Parkinson’s disease. Phase 1b/2a data showed that the asset can improve motor function and mobility in patients.
March 23, 2026
·
2 min read
·
Tristan Manalac
Cell Therapy
6 Companies Hanging On in Cell Therapy
As big pharmas including Takeda and Novo Nordisk flee the cell therapy space and smaller biotechs shutter their operations, these players are sticking around to take the modality as far as it can go.
December 1, 2025
·
9 min read
·
Tristan Manalac
Manufacturing
AstraZeneca Building Shanghai Production Plant to Support Cell Therapy Strategy
The company is establishing commercial production capabilities to fuel plans to launch autologous CAR T cell therapies in China.
March 19, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
February 13, 2026
·
5 min read
Press Releases
Xcell Biosciences and Culture Biosciences Partner to Advance Cell Therapy Quality Through AI and Machine Learning
December 10, 2025
·
4 min read
Press Releases
Precision Cell Systems Acquires BennuBio to Enter the 3D Cell Culture Market
October 2, 2025
·
3 min read
1 of 71,043
Next